Chantix Update: FDA Evaluating Reports of Suicidal Thoughts In Chantix Users

On November 20, 2007, the Food and Drug Administration ("FDA") reported that it is evaluating post-marketing adverse event reports about Pfizer Inc.'s smoking cessation drug Chantix upon receiving company submitted reports about Chantix users having suicidal thoughts.

The FDA asked Pfizer for the reports. The FDA said that while it analyzed data, it recommends that health care providers monitor Chantix patients for behavior and mood changes. The FDA said patients should report behavior and mood changes to their doctors.

Claudine Q. Homolash, Esq. represents consumers who have been injured as a result of dangerous drugs and other products.

Serious Side-Effects Linked to the Smoking Cessation Drug Chantix

The smoking cessation drug, Chantix, is manufactured and distributed by Pfizer, a pharmaceutical titan in terms of profits and influence. Chantix was marketed as a promising drug which was designed to work in conjunction with behavior modification therapy to help people work towards leaving their smoking habit behind for good.

Initially, minor side-effects were reported, such as nausea and dizziness, but as time progressed, the known side-effects became more serious. Reported side-effects include chronic feelings of extreme anxiety and depression, up to and including thoughts of suicide and acts of abuse.

Discovery remains ongoing in regards to Chantix, but if you're using it, seek medical attention immediately, especially if you're feeling any potential side-effects. If you have experienced side-effects regarding this drug, contact me directly so I can assist in investigating a potential claim on your behalf.

Claudine Q. Homolash is a personal injury attorney representing individuals injured by dangerous drugs and other products. Ms. Homolash represents injured individuals in litigations involving, but not limited to, the drugs Vioxx, Bextra, and Gadolinium. Ms. Homolash also represents plaintiffs in against Boston Scientific (formerly Guidant) and Medtronic.